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ABSTRACT
To examine the role of iron in mediating hepatocellular damage during reperfusion after
hemorrhagic shock, we studied five groups of n=4 or 5 dogs, bled to reduce mean
arterial pressure to 35 mmHg (± 5mrnHg) for three hours and subsequently treated 20
minutes prior to reinfusion of shed blood with either 0.9% saline, 5 ml/kg; deferoxam
ine, 50 µg/kg in 0.9% saline; 6% pentastarch solution, 5 ml/kg; deferoxamine covalently
bound to 6% pentastarch, 50 µg/kg; or iron loaded deferoxamine in 0.9% saline.
Saturation of iron binding capacity increased during hemorrhagic shock and remained
high in all but the deferoxamine pentastarch treated group. Serum iron levels were
significantly lower in animals treated with saline or iron loaded deferoxamine. Serum
alanine aminotransferase (ALT), a specific marker for hepatocellular injury in the dog,
was measured as an indicator of hepatic reperfusion injury. During shock, ALT did not
change significantly from the normal in any group. After reperfusion, however, ALT
rose sharply in animals reperfused without iron chelators, from a mean baseline value of
less than 36 U/L to a post-reperfusion plateau of 5509

± 2260 U/L at four hours, a pat

tern suggesting hepatic reperfusion injury. Iron loaded deferoxamine control dogs, also
showed a substantial rise in ALT activity to 6287

± 2134 U/L four hours after reperfu

sion. However, dogs treated with free deferoxamine showed significantly smaller eleva
tions in ALT to only 655

± 139 U/L (P

<0.05). Histologic evaluation of liver sections

showed significantly smaller areas of necrosis in both of the deferoxamine treated groups
compared to other groups. These findings suggest that deferoxamine preventable reper
fusion injury of the liver, perhaps involving the iron catalyzed Haber-Weiss reaction,
may play a role in the pathophysiology of hemorrhagic shock.
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